Study of HRS-1780 for chronic kidney disease
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests an investigational drug called HRS-1780 in people with chronic kidney disease. It aims to see if the drug can help slow kidney decline and is safe to use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 79 years old
- Your kidney function (eGFR) is between 25 and 90, with specific protein levels in urine
- Your blood potassium level is 4.8 mmol/L or lower
- Your blood sugar control (HbA1c) is less than 10.5%
- You do not have uncontrolled high blood pressure, severe liver problems, or certain kidney diseases
- You have not had a stroke, heart attack, or kidney transplant in the last 90 days, and you are not on dialysis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests HRS-7535, a new oral tablet that may help protect kidneys in people with chronic kidney disease. GLP-1 medications were originally developed for diabetes but may also benefit kidney function and overall health.
This trial tests whether a new drug called SAL0140 can help people with chronic kidney disease who have protein leaking into their urine. The study will look at different doses to find the safest and most effective amount.
This trial tests a medication called EC5026 in people with and without chronic kidney disease (CKD) to see how the body handles it. It helps understand if dose adjustments are needed for people with impaired kidney function.
This study tests a new drug called OJR520 to see if it's safe and how the body processes it. It first tests healthy volunteers and then people with chronic kidney disease to understand the drug's effects.
This study tests whether a new medicine called HS-10390 can slow kidney disease and reduce protein leaking into urine in people with moderate kidney damage. You must already be taking blood pressure medications (ACE inhibitors or ARBs) to qualify.
This study is collecting information from people with chronic kidney disease (CKD) to understand how the disease progresses over time. It does not test any new treatments, so you keep your usual care.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.